Collaborator: Policy Lab U.S
Link
Summary:
This study is a prospective Phase 2, drug controlled, dose-controlled study to evaluate the safety and efficacy of Pure Green sublingual tablets for the treatment of pain associated with osteoarthritis of the knee.
Recruitment Status: Recruiting
Study Details:
Sponsor: Pure Green
Information provided by (Responsible Party): Pure Green
Condition or Disease: Osteoarthritis, Knee Pain
Intervention/ Treatment: Drug: Test Article
Phase: Phase 2
Study Type: Interventional (Clinical Trial)
Estimated Enrolment: 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Dose Controlled Osteoarthritis of the Knee Pain Study Using CBD and THC in Rapidly Dissolvable Sublingual Tablet
Estimated Study Start Date: December 9, 2019
Estimated Primary Completion Date: February 1, 2020
Estimated Study Completion Date: April 1, 2020
